JNCI Monographs

1

Gene Profiling Assay and Application: The Predictive Role in Primary Therapy

Fumagalli, D., Desmedt, C., Ignatiadis, M., Loi, S., Piccart, M., Sotiriou, C.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 168 KB

english, 2011

2

New Omics Information for Clinical Trial Utility in the Primary Setting

Damia, G., Broggini, M., Marsoni, S., Venturini, S., Generali, D.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 322 KB

english, 2011

3

Mechanisms of Resistance to HER2 Target Therapy

Tortora, G.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 145 KB

english, 2011

4

Intermediate Endpoints of Primary Systemic Therapy in Breast Cancer Patients

Berruti, A., Generali, D., Bertaglia, V., Brizzi, M. P., Mele, T., Dogliotti, L., Bruzzi, P., Bottini, A.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 172 KB

english, 2011

5

Tissue and Soluble Biomarkers in Breast Cancer and Their Applications: Ready to Use?

Danova, M., Delfanti, S., Manzoni, M., Mariucci, S.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 142 KB

english, 2011

6

Neoadjuvant Chemotherapy: Early Response as a Guide for Further Treatment: Clinical, Radiological, and Biological

Untch, M., von Minckwitz, G.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 262 KB

english, 2011

7

The HER2 World: Better Treatment Selection for Better Outcome

Tagliabue, E., Campiglio, M., Pupa, S. M., Balsari, A., Menard, S.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 186 KB

english, 2011

8

The Treatment of Individual Patients Is More Than a Trial

Bottini, A., Berruti, A., Generali, D., Dogliotti, L.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 93 KB

english, 2011

9

Erratum

Journal:

JNCI Monographs

Year:

2011

File:

PDF, 47 KB

2011

10

kConFab: A Familial Breast Cancer Consortium Facilitating Research and Translational Oncology

Thorne, H., Mitchell, G., Fox, S.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 132 KB

english, 2011

11

Cover

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

12

The Triple-Negative Subtype: New Ideas for the Poorest Prognosis Breast Cancer

Curigliano, G., Goldhirsch, A.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 157 KB

english, 2011

14

Positron Emission Tomography and Neoadjuvant Therapy of Breast Cancer

Cochet, A., Generali, D., Fox, S. B., Ferrozzi, F., Hicks, R. J.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 174 KB

english, 2011

15

Editorial Board

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 32 KB

english, 2011

16

Neoadjuvant Chemotherapy and Targeted Therapies: a Promising Strategy

Metzger-Filho, O., de Azambuja, E.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 186 KB

english, 2011

17

The Value of Genomic Analysis of Breast Cancer in Drug Development

Szekely, B., Pusztai, L.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 164 KB

english, 2011

18

Strategies to Translate Preclinical Information to Breast Cancer Patient Benefit

Daidone, M. G., Zaffaroni, N., Cappelletti, V.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 404 KB

english, 2011

19

The Pathologic Complete Response Open Question in Primary Therapy

Marchio, C., Sapino, A.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 190 KB

english, 2011

20

Predictive Immunohistochemical Biomarkers in the Context of Neoadjuvant Therapy for Breast Cancer

Generali, D., Symmans, W. F., Berruti, A., Fox, S. B.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 198 KB

english, 2011

21

Assessing Early Therapeutic Response to Bevacizumab in Primary Breast Cancer Using Magnetic Resonance Imaging and Gene Expression Profiles

Mehta, S., Hughes, N. P., Buffa, F. M., Li, S. P., Adams, R. F., Adwani, A., Taylor, N. J., Levitt, N. C., Padhani, A. R., Makris, A., Harris, A. L.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 323 KB

english, 2011

22

Endocrine Therapy, New Biologicals, and New Study Designs for Presurgical Studies in Breast Cancer

Dowsett, M., Smith, I., Robertson, J., Robison, L., Pinhel, I., Johnson, L., Salter, J., Dunbier, A., Anderson, H., Ghazoui, Z., Skene, T., Evans, A., A'Hern, R., Iskender, A., Wilcox, M., Bliss, J.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 406 KB

english, 2011

23

Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Blood Oxygenation Level-Dependent Magnetic Resonance Imaging for the Assessment of Changes in Tumor Biology With Treatment

Li, S. P., Padhani, A. R., Makris, A.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 616 KB

english, 2011

24

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010)

Berruti, A., Generali, D., Kaufmann, M., Puztai, L., Curigliano, G., Aglietta, M., Gianni, L., Miller, W. R., Untch, M., Sotiriou, C., Daidone, M., Conte, P., Kennedy, D., Damia, G., Petronini, P., Di

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 161 KB

english, 2011

25

Biomarkers Predicting Clinical Benefit: Fact or Fiction?

Guarneri, V., Barbieri, E., Conte, P.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 143 KB

english, 2011

26

Bridging the Gap Between Translational Research and Clinical Application

Miller, W. R., Larionov, A. A.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 286 KB

english, 2011

27

Surrogate Markers for Targeted Therapy-Based Treatment Activity and Efficacy

Bianchini, G., Gianni, L.

Journal:

JNCI Monographs

Year:

2011

Language:

english

File:

PDF, 152 KB

english, 2011

Volume 2011; Issue 43

Gene Profiling Assay and Application: The Predictive Role in Primary Therapy

New Omics Information for Clinical Trial Utility in the Primary Setting

Mechanisms of Resistance to HER2 Target Therapy

Intermediate Endpoints of Primary Systemic Therapy in Breast Cancer Patients

Tissue and Soluble Biomarkers in Breast Cancer and Their Applications: Ready to Use?

Neoadjuvant Chemotherapy: Early Response as a Guide for Further Treatment: Clinical, Radiological, and Biological

The HER2 World: Better Treatment Selection for Better Outcome

The Treatment of Individual Patients Is More Than a Trial

Erratum

kConFab: A Familial Breast Cancer Consortium Facilitating Research and Translational Oncology

Cover

Table of Contents

The Triple-Negative Subtype: New Ideas for the Poorest Prognosis Breast Cancer

Positron Emission Tomography and Neoadjuvant Therapy of Breast Cancer

Editorial Board

Neoadjuvant Chemotherapy and Targeted Therapies: a Promising Strategy

The Value of Genomic Analysis of Breast Cancer in Drug Development

Strategies to Translate Preclinical Information to Breast Cancer Patient Benefit

The Pathologic Complete Response Open Question in Primary Therapy

Predictive Immunohistochemical Biomarkers in the Context of Neoadjuvant Therapy for Breast Cancer

Assessing Early Therapeutic Response to Bevacizumab in Primary Breast Cancer Using Magnetic Resonance Imaging and Gene Expression Profiles

Endocrine Therapy, New Biologicals, and New Study Designs for Presurgical Studies in Breast Cancer

Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Blood Oxygenation Level-Dependent Magnetic Resonance Imaging for the Assessment of Changes in Tumor Biology With Treatment

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010)

Biomarkers Predicting Clinical Benefit: Fact or Fiction?

Bridging the Gap Between Translational Research and Clinical Application

Surrogate Markers for Targeted Therapy-Based Treatment Activity and Efficacy